AstraZeneca Reports Q2 Earnings Next Week. What Investors Should Expect.Tip Ranks·1 day ago, 07:38 AMAZN+0.59%AZN
AstraZeneca asthma inhaler Trixeo wins positive EU CHMP opinion for approvalPUBT·1 day ago, 05:38 AMAZN+0.59%AZN
Public Employees Retirement System of Ohio Buys 677,700 Shares of Astrazeneca Plc $AZNMarket Beat·1 day ago, 05:35 AMAZN+0.59%AZNH0.00%
Harbour BioMed Announces Positive Profit Alert for 2026 Interim Results, Marking Seventh Consecutive Profitable Half-Year as Platform-Based Advantages Drive Sustainable GrowthPR Newswire·2 days ago, 07:02 PM02142+1.30%BMY+0.94%
AstraZeneca’s Etcamah-CDK4/6 combo wins EU approval for 1st-line advanced ER-positive breast cancerPUBT·Jul 23 at 01:11 AMAZN+0.59%AZN
AZN Investors Have Opportunity to Join AstraZeneca PLC Fraud Investigation with the Schall Law FirmMorningStar·Jul 22 at 08:07 PMAZN+0.59%AZN
Royalty Pharma acquires royalty interest in AstraZeneca’s cliramitug for up to $425 million from Neurimmune | RPRX Stock NewsStockTitan·Jul 21 at 10:05 PMAZN+0.59%RPRX-0.32%
